Phoenix PharmaLabs Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.66M

  • Investors
  • 10

Phoenix PharmaLabs General Information

Description

Developer of pain therapy drugs designed to treat pain and opiate addiction. The company specializes in the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction, enabling healthcare professionals to treat addiction in an effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 999 West 1500 South
  • Suite 600
  • Woods Cross, UT 84087
  • United States
+1 (312)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 999 West 1500 South
  • Suite 600
  • Woods Cross, UT 84087
  • United States
+1 (312)

Phoenix PharmaLabs Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phoenix PharmaLabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 15-May-2023 $5.66M Completed Pre-Clinical Trials
10. Seed Round 06-Oct-2022 Completed Pre-Clinical Trials
9. Grant 06-Oct-2022 Completed Pre-Clinical Trials
8. Grant 30-Sep-2022 Completed Pre-Clinical Trials
7. Equity Crowdfunding 18-Jun-2021 Completed Pre-Clinical Trials
6. Angel (individual) Completed Pre-Clinical Trials
5. Equity Crowdfunding 08-Apr-2019 Completed Pre-Clinical Trials
4. Grant 01-Jan-2018 Completed Pre-Clinical Trials
3. Grant 01-Jan-2011 $400K $270K Completed Startup
2. Angel (individual) 01-Jan-2011 $270K $270K Completed Startup
To view Phoenix PharmaLabs’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phoenix PharmaLabs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pain therapy drugs designed to treat pain and opiate addiction. The company specializes in the development
Drug Discovery
Woods Cross, UT
8 As of 2025

Barcelona, Spain
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Phoenix PharmaLabs Competitors (4)

One of Phoenix PharmaLabs’s 4 competitors is Ability Pharma, a Private Equity-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Private Equity-Backed Barcelona, Spain
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Neurotez Private Equity-Backed Jersey City, NJ
Collegium Pharmaceutical Formerly VC-backed Stoughton, MA
To view Phoenix PharmaLabs’s complete competitors history, request access »

Phoenix PharmaLabs Patents

Phoenix PharmaLabs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200276186-A1 Use of morphinans for treating cocaine addiction, pruritis, and seizure disorders Inactive 20-Nov-2017
CA-2822453-A1 Novel morphinans useful as analgesics Active 23-Dec-2010
ES-2604931-T3 New morphinans useful as analgesics Active 23-Dec-2010
US-8987293-B2 Morphinans useful as analgesics Active 23-Dec-2010
US-20130338182-A1 Novel morphinans useful as analgesics Active 23-Dec-2010 C07D221/28
To view Phoenix PharmaLabs’s complete patent history, request access »

Phoenix PharmaLabs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phoenix PharmaLabs Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Central Texas Angel Network Angel Group Minority
United States Department of Defense Government
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 10 investors. Get the full list »

Phoenix PharmaLabs FAQs

  • When was Phoenix PharmaLabs founded?

    Phoenix PharmaLabs was founded in 2002.

  • Where is Phoenix PharmaLabs headquartered?

    Phoenix PharmaLabs is headquartered in Woods Cross, UT.

  • What is the size of Phoenix PharmaLabs?

    Phoenix PharmaLabs has 8 total employees.

  • What industry is Phoenix PharmaLabs in?

    Phoenix PharmaLabs’s primary industry is Drug Discovery.

  • Is Phoenix PharmaLabs a private or public company?

    Phoenix PharmaLabs is a Private company.

  • What is Phoenix PharmaLabs’s current revenue?

    The current revenue for Phoenix PharmaLabs is .

  • How much funding has Phoenix PharmaLabs raised over time?

    Phoenix PharmaLabs has raised $7.07M.

  • Who are Phoenix PharmaLabs’s investors?

    Central Texas Angel Network, United States Department of Defense, , , and are 5 of 10 investors who have invested in Phoenix PharmaLabs.

  • Who are Phoenix PharmaLabs’s competitors?

    Ability Pharma, Centrexion Therapeutics, Neurotez, and Collegium Pharmaceutical are competitors of Phoenix PharmaLabs.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »